EATG » News

AIDS 2018: The programme of the European Civil Society Forum booth in the Global Village is now online

The EATG and AIDS Action Europe are co-hosting the European Civil Society Forum (booth 618) at the Global Village of the 22nd International AIDS Conference in Amsterdam. Organisations and activists…

Ageing with HIV conference outcomes: read watch and register to discuss

The EATG organised a conference titled ‘New challenges and unmet needs of people living and ageing with HIV/AIDS aged 18-50, Quality of Life and Preventive Healthcare’ from 3 to 6…

EATG’s new term as a member of the Civil Society Forum on Drugs (2018-2021)

This week the European AIDS Treatment Group participated in the first meeting of the new 3-year term of the Civil Society Forum on Drugs that took place in Brussels. The CSFD…

What is on the minds of PLHIV in Europe in terms of their long term health?

Results: Long term health perspectives of people living with HIV in Europe   The EATG in collaboration with Volle Maan Communicatie Bureau conducted a study titled ‘Long term health perspectives…

EHVA: a clinical trial for therapeutic vaccination for HIV is about to start

Today and tomorrow EATG is attending the European HIV Vaccine Alliance (EHVA) consortium meeting in Barcelona. The EATG is one of the 39 partners of the consortium that aims to develop…

Position on scaling up HIV self-testing and self-sampling

Just published - an opinion piece on scaling up HIV self-testing and self-sampling, by the HIV in Europe Initiative (a European civil society, policy makers, health professionals and public health…

A more social Europe needs a more robust Health Programme

The EU Civil Society Forum on HIV, TB and Hepatitis, gathering leading civil society organisations at the national and regional level in the EU and neighbouring countries, welcomes with caution the…

EATG 2017 annual report is out now

2017 was the year that marked 25 exciting years of HIV/AIDS activism for the European AIDS Treatment Group. A year working towards achieving our goals and objectives is condensed in…

Call for organisations and activists to present at the European NGO booth (world AIDS 2018 conference)

We are happy to invite organisations and activists in Europe and Central Asia to present, discuss, share and learn at European NGO booth at the world AIDS 2018 Amsterdam conference.…

EATG launches a report on access to HCV-related services in prison settings in Europe

Today, the European AIDS Treatment Group launches a report along with recommendations on access to HCV-related services in prison settings in Europe. At the same time, a pilot Spring European…

Civil society organizations come forth with a Joint Statement in advance of the 39th meeting of the Global Fund Board

With a joint statement addressed to the Global Fund, more than 40 international, regional and national organizations have voiced their deep concerns regarding Global Fund's eligibility policy and the limitations…

Ageing with HIV: New challenges and unmet needs of people aged 18 – 50 years living and ageing with HIV/AIDS (3-6 May 2018, Kiev)

The closing meeting from the third phase of the Ageing with HIV project is kicking off tomorrow in Kiev and will run until Sunday. We are excited to welcome 94…

Webinar: Results of the METRODORA research on the involvement of women in HIV clinical trials

EATG will host a webinar on the Results of the METRODORA research on the involvement of women in HIV clinical trials on Wednesday, 02 May 2018, 13:00 – 14:00 CEST…

Webinar: Introduction to medicine research and development

EATG will host a webinar, Introduction to medicine research and development, on Thursday, 26 April 2018, 18:00 – 19:00 CEST (Brussels, Berlin, Paris time). The webinar will be led by…

Positive Stories: the voices of women living with HIV across Europe

The EATG has launched a new initiative aiming to give women living with or affected by HIV a platform to make their voices heard. Positive Stories is an empowerment tool…

Grindr sharing the HIV status and other personal information of their users with third parties without their informed consent is unacceptable

The EATG is disturbed by the news, reported by BuzzFeed News, about Grindr sharing the HIV status information of their users with two third companies, Apptimize and Localytics. Such actions…

PARADIGM: A collaborative initiative on patient engagement kicks-off

PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines), a new initiative regarding patient engagement in research and development of medicines, was launched this week during…

STEP-UP 2018/19: Call for participants

The European AIDS Treatment Group (EATG) is happy to launch the call for participants for the STEP-UP 2018/19 training programme today. The STEP-UP programme is designed for people living with…

Metrodora: Webinar on women’s participation in HIV research

EATG will host a webinar on women’s participation in HIV research on 4 April 2018, 17:00 – 18:00 CET (Brussels, Berlin, Paris time). The webinar is organized within the context…

Civil society and patient organisations are seeking EU leadership and action on HIV, Hepatitis and TB

The European AIDS Treatment Group, along with other civil society and patients organisations, has co-signed an open letter to Commissioner Andriukaitis in view of the upcoming Staff Working Document on…

AIDS 2018: Sign the Amsterdam Affirmation

Much has changed since the global HIV community convened at the previous International AIDS Conference in Durban in 2016. Advances in science have been significant, including widespread acceptance that HIV…

HIV treatment-as-prevention is effective in homosexual male couples, study finds

A study led by the Kirby Institute at UNSW supports evidence that treatment-as-prevention allows people living with HIV to have effectively zero chance of sexually transmitting the virus to others.…

NHS England and local authorities must ensure routine availability of PrEP for HIV prevention by 1 April 2019, says coalition of charities

• 32 organisations demand HIV prevention drug PrEP to be routinely available on the NHS by 1 April 2019 • The current three-year trial will provide PrEP to 10,000 people…

The Netherlands: After years of foot-dragging: a meager PrEP decision with no ambition

July 11, 2018: Yesterday, Dutch Minister of Health, Welfare and Sport Bruno Bruins announced his plan to provide PrEP for the next five years to a group of gay men…

Why don’t more Americans use PrEP?

It could wipe out H.I.V. in America, but its high price keeps it out of reach for too many. On July 3, 1981, this newspaper wrote about a “rare cancer”…

Reported ‘PrEP failure’ in Thailand may be a result of missing acute HIV infection: Here’s what you need to know

The Infectious Diseases Society of America reported on June 29, 2018, that a new HIV acquisition had been found in a person using pre-exposure prophylaxis (PrEP). According to the journal…

FDA approves SYMTUZA

Janssen announces U.S. FDA approval of SYMTUZA (D/C/F/TAF), the first and only complete darunavir-based single-tablet regimen for the treatment of HIV-1 infection Read the press release here.

ECDC: Chlamydia infection – Annual epidemiological report for 2016

The European Centre for Disease Prevention and Control (ECDC) released Chlamydia infection - Annual epidemiological report for 2016. The report can be downloaded here.

Are HIV self-tests an economically feasible method of testing?

HIV testing is a first step and key to stemming the rate of HIV infections around the world. In sub-Saharan African countries, HIV testing rates continue to be suboptimal, creating…

Kenyan women can distribute HIV self-test kits to their sexual partners without a significant risk of intimate partner violence

The distribution of HIV self-testing kits by women to their sexual partners doesn't increase women's risk of intimate partner violence, according to Kenyan research published in the Journal of Acquired…

South Africa slashes new HIV cases by almost half

The country’s investments in HIV treatment and prevention are paying off, leading to huge reductions in new infections New HIV infections in South Africa have fallen by 44% in the…

Viral suppression for HIV treatment success and prevention of sexual transmission of HIV

July 2018 – The World Health Organization (WHO) leads the health sector response to HIV as part of the Joint United Nations Programme on HIV/AIDS. WHO works to increase access…

Source:
WHO
Read more...

Statement by AfroCAB on DTG and neural tube defects in WLHIV of child bearing age

The African Community Advisory Board (AfroCAB) released a statement on dolutegravir (DTG) and neural tube defects in women living with HIV (WLHIV) of child bearing age. "Since information has been…

New agreements with HIV drug suppliers to save $324 million

PEPFAR chief wants 70 percent ‘indigenous’ funding in 30 months

BALTIMORE, 16 July 2018 — The United States government’s flagship global HIV and AIDS program is going local, even as its leaders try to figure out how exactly that will work.…

Brussels to Amsterdam walk to demand access to HIV treatment

Four activists from Australia, South Africa and the UK embarked on an HIV awareness walk from Brussels Grand Place Sunday (July 15) morning. They will spend 9 days walking to…

CytoDyn announces positive results from completed pivotal PRO 140 HIV combination trial

Approximately 81% of patients completing PRO 140 trial demonstrated suppressed viral load with plasma HIV-1 RNA viral load of less than 50 copies/mL and 92% had viral load of less…

ECDC: Gonorrhoea – Annual epidemiological report for 2016

The European Centre for Disease Prevention and Control (ECDC) released Gonorrhoea - Annual epidemiological report for 2016. The report can be downloaded here.

EMA’s proactive publication of clinical data a success

First report on unprecedented transparency policy shows high user satisfaction The European Medicines Agency (EMA) has published the first report on the implementation of its flagship policy on the publication…

Source:
EMA
Read more...

Younger adults with HIV experience shorter times to viral rebound

A Canadian study found that a patient's age was a factor in HIV viral rebound after suppression with treatment, with younger adults experiencing lower prevalence of viral suppression and shorter…